搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

Human growth-regulated oncogeneα/melanoma growth stimulating activity,GROα/MGSA ELISA Kit

  • 中文名稱:
    人生長調(diào)節(jié)致癌基因α/黑素瘤生長刺激因子(GROα/CXCL1/MGSA)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-E09150h
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人生長調(diào)節(jié)致癌基因α/黑素瘤生長刺激因子(GROα/CXCL1/MGSA)酶聯(lián)免疫試劑盒(CSB-E09150h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的CXCL1含量。CXCL1屬于趨化因子,在炎癥、免疫反應(yīng)等生理過程中發(fā)揮重要作用。其背景與機體防御和疾病發(fā)生相關(guān)。研究機制上,它能與特定受體結(jié)合,介導(dǎo)細(xì)胞趨化,在腫瘤生長、血管生成以及炎癥性疾病進展中扮演關(guān)鍵角色,是潛在治療靶點。試劑盒檢測范圍為78 pg/ml- 5000 pg/ml,靈敏度為19.5 pg/ml。本試劑盒適用于體外實驗中對GROα的定量分析,可服務(wù)于基礎(chǔ)科研領(lǐng)域如炎癥機制研究、腫瘤微環(huán)境模型構(gòu)建、藥物干預(yù)效果評估等方向,支持科研人員從動物模型、細(xì)胞培養(yǎng)或臨床前樣本中獲取GROα的動態(tài)表達數(shù)據(jù),為相關(guān)疾病的分子機制探索提供可靠工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    C-X-C motif chemokine 1 ELISA Kit; Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity; alpha) ELISA Kit; chemokine (C-X-C motif) ligand 1 ELISA Kit; CINC-1 ELISA Kit; CXCL1 ELISA Kit; Cytokine-induced neutrophil chemoattractant 1 ELISA Kit; Fibroblast secretory protein ELISA Kit; Fsp ELISA Kit; Gro 1 ELISA Kit; Gro A ELISA Kit; Gro ELISA Kit; GRO protein; alpha ELISA Kit; GRO-alpha(1-73) ELISA Kit; GRO-alpha(6-73) ELISA Kit; Gro1 ELISA Kit; GRO1 oncogene (melanoma growth stimulating activity; alpha) ELISA Kit; GRO1 oncogene (melanoma growth-stimulating activity) ELISA Kit; Gro1 oncogene ELISA Kit; GROa ELISA Kit; GROA_HUMAN ELISA Kit; Growth-regulated alpha protein ELISA Kit; KC ELISA Kit; KC chemokine; mouse; homolog of ELISA Kit; melanoma growth stimulatory activity alpha ELISA Kit; Melanoma growth stimulatory activity ELISA Kit; Melanoma growth stimulatory activity; alpha ELISA Kit; MGSA alpha ELISA Kit; MGSA ELISA Kit; MGSA-a ELISA Kit; N51 ELISA Kit; NAP-3 ELISA Kit; NAP3 ELISA Kit; Neutrophil-activating protein 3 ELISA Kit; Platelet-derived growth factor-inducible protein KC ELISA Kit; Scyb 1 ELISA Kit; Scyb1 ELISA Kit; Secretory protein N51 ELISA Kit; Small inducible cytokine subfamily B; member 1 ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    78 pg/ml - 5000 pg/ml
  • 靈敏度:
    19.5 pg/ml
  • 反應(yīng)時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領(lǐng)域:
    Immunology
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

  • 線性度:

    To assess the linearity of the assay, samples were spiked with high concentrations of human GROα/CXCL1/MGSA in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

    Sample

    Serum(n=4)

    1:1

    Average %

    104

    Range %

    98-110

    1:2

    Average %

    97

    Range %

    91-105

    1:4

    Average %

    98

    Range %

    92-106

    1:8

    Average %

    93

    Range %

    86-98

  • 回收率:

    The recovery of human GROα/CXCL1/MGSA spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

    Sample Type

    Average % Recovery

    Range

    Serum (n=5)

    94

    89-99

    EDTA plasma (n=4)

    99

    92-108

  • 標(biāo)準(zhǔn)曲線:

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

    pg/ml

    OD1

    OD2

    Average

    Corrected

    5000

    2.543

    2.634

    2.589

    2.421

    2500

    2.135

    2.167

    2.151

    1.984

    1250

    1.574

    1.528

    1.551

    1.384

    625

    0.980

    0.959

    0.969

    0.802

    312

    0.550

    0.521

    0.536

    0.368

    156

    0.355

    0.343

    0.349

    0.182

    78

    0.260

    0.274

    0.267

    0.100

    0

    0.165

    0.170

    0.167

     

  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

引用文獻

產(chǎn)品評價

靶點詳情

  • 功能:
    Has chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine fashion. In vitro, the processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity.
  • 基因功能參考文獻:
    1. The chemokine Gro1 induced in response to inflammation triggers senescence and arrests development of new neurons in the hippocampus and that the magnitude of this response is sex-dependent. PMID: 30201019
    2. CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105. PMID: 30115896
    3. These results show that AKIP1 is crucial in cervical cancer angiogenesis and growth by elevating the levels of the NF-kappaB-dependent chemokines CXCL1, CXCL2, and CXCL8. PMID: 29520695
    4. Adipose stromal cells recruitment to tumours, driven by CXCL1 and CXCL8, promotes prostate cancer progression. PMID: 27241286
    5. CXCL1, which is produced by breast cancer cells, can promote cancer growth and development PMID: 29438938
    6. miR-204 inhibits cell proliferation in gastric cancer by targeting CKS1B, CXCL1 and GPRC5A. PMID: 29283424
    7. Thrombocytosis was more prevalent in patients with inflammatory breast cancer (IBC)than in those with non-IBC and it was associated with poor prognosis. GRO and TGF-beta were associated with thrombocytosis in IBC PMID: 28831670
    8. the plasma concentrations of CXCL1 indicated the disease activity and prognosis in interstitial pneumonia with autoimmune features (IPAF). Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF. PMID: 27958346
    9. CXCL1/8 secreted by adipose-derived mesenchymal stem cells could promote breast cancer angiogenesis. PMID: 28514506
    10. GROA overexpression is associated with invasion in triple negative breast cancer. PMID: 28560447
    11. The results of the transwell chemotaxis assay also supported the above results. Our data suggest that APN can promote h-JBMMSC chemotaxis by up-regulating CXCL1 and CXCL8 PMID: 28176455
    12. This study highlighted CAF-secreted CXCL1 as an attractive target to reverse tumor radioresistance. PMID: 28518141
    13. we identified the microRNA miR-200a as a putative post-transcriptional regulator of CXCL1 in hepatocellular carcinoma PMID: 27542259
    14. study demonstrates that CXCL1 can transform NOFs into senescent CAFs via an autocrine mechanism PMID: 29360827
    15. Association of polymorphic markers of chemokine genes, their receptors, and CD14 gene with coronary atherosclerosis PMID: 29369549
    16. GROalpha high in the tumor microenvironment can be used as potential indicators for the progression of non-small cell lung cancer PMID: 28375674
    17. IL-8, but not the CXCL1 circuit, is critical for the regulation of thyroid cancer stem cells. PMID: 27577959
    18. this study shows that CXCL1 is expressed in epithelium of the endometrium with adenomyosis and demonstrate that VEGF is capable of inducing CXCL1 expression PMID: 27665197
    19. Taken together, the present study indicates that IL-33 localized in the human atherosclerotic plaque increases GRO-alpha mRNA expression and protein secretion via activation of ERK1/2, JNK, and NF-kappaB in HUVECs, suggesting that IL-33 plays an important role in the pathophysiology and development of atherosclerosis. PMID: 28637660
    20. Study provides the first evidence that primary malignant cell-secreted VEGFA stimulates tumor-associated macrophages to produce CXCL1, which recruits CXCR2-positive MDSCs to form a premetastatic niche to promote liver metastases. PMID: 28455419
    21. the presence of elevated circulating levels of VEGF and CXCL1 are predictive of liver and lung metastasis, respectively of colorectal cancer. PMID: 28870907
    22. This study describe elevated levels of CXCL1 and it receptor in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma, relative to other pediatric brain tumors and normal cerebral tissue. PMID: 28859336
    23. The expressions of CXCL1 in cancer cells and CXCR2 in stromal cells are useful prognostic factors for gastric cancer patients PMID: 28575019
    24. CXCL1 secreted by tumor-associated lymphatic endothelial cells promotes lymph node metastasis of gastric cancer through integrin beta1/FAK/AKT signaling pathway. PMID: 27832972
    25. S100A9 and S100A12 may have a role in the pathogenesis of pneumonia: S100A9 and CXCL1 may contribute solely in mild pneumonia, and CCL5 and CXCL11 may contribute in severe pneumonia. PMID: 28381820
    26. These findings support a role for CXCL1 and IL-8 in cystic fibrosis lung disease severity and identify STAT3 as a modulating pathway. PMID: 27799352
    27. Results suggest that CXCL1 is a key molecular link between senescence of stromal fibroblasts and tumor growth. PMID: 27092462
    28. Increased IL-8 and CXCL1 transcription in T84 and THP-1 cells compared to that in wild-type EPEC. PMID: 27297392
    29. CXCL1 signaling in the tumor microenvironment is highly responsible for repeated intravesical recurrence, disease progression, and drug resistance through enhanced invasion ability. In conclusion, disrupting CXCL1 signaling to dysregulate this chemokine is a promising therapeutic approach for human UCB. PMID: 27690238
    30. Silencing of the CXCL1 gene inhibits HGC803 cell migration and invasion. The positive expression of CXCL1 is correlated with poor survival of gastric cancer patients and CXCL1 is an independent prognostic factor for gastric cancer. PMID: 27748927
    31. These results demonstrate that tumor-derived CXCL1 contributes to TANs infiltration in lung cancer which promotes tumor growth. PMID: 27446967
    32. the serum levels of the soluble factors sCD40L and CXCL1 are not associated with endometriosis and are not suitable as biomarkers for disease diagnosis. PMID: 27190986
    33. Elevated expression of GRO-alpha in cytoplasm of cancer cells (hazard ratio [HR] = 5.730, P = 0.007) and stroma (HR = 3.120, P = 0.022) were independent prognostic factors of pancreatic cancer. T classification (HR = 2.130, P = 0.023), lymphatic metastasis (HR = 4.211, P = 0.009) and TNM classification (HR = 0.481, P = 0.031) were also prognostic predictors in PC patients. PMID: 27472713
    34. The novel findings reveal the critical role of NLRP12-IL-17A-CXCL1 axis in host defense by modulating neutrophil recruitment against Klebsiella pneumoniae. PMID: 26349659
    35. increased amounts released by neutrophils from fibromyalgia patients PMID: 26341115
    36. these findings suggest that CXCL1 plays critical roles in the growth and apoptosis of hepatocellular carcinoma PMID: 26499374
    37. BBP also stimulated the production of CXCL1/GROalpha by TADCs, which increased the angiogenesis of breast cancer in a mouse model PMID: 26397389
    38. Intense glomerular CXCL1 expression was observed in biopsy specimens from patients with lupus nephritis PMID: 25471749
    39. hCXCL1-GAG interactions provide stringent control over regulating chemokine levels and receptor accessibility and activation, and that chemotactic gradients mediate cellular trafficking to the target site. PMID: 26721883
    40. Urine CXCL1 is a promising, non-invasive molecular marker for tumor detection and outcome prediction in patients with bladder cancer . PMID: 26406865
    41. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma PMID: 26503598
    42. Polymorphisms in the promoter regions of the CXCL1 and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population PMID: 26345899
    43. VEGF markedly induces CXCL1 release in A549 lung epithelial cells. PMID: 23665907
    44. TGF-beta negatively regulates CXCL1 expression in CAFs through Smad2/3 binding to the promoter, and through suppression of HGF/c-Met autocrine signaling PMID: 26252654
    45. work shows parallel networks of necroptosis-induced CXCL1 and Mincle signalling that promote macrophage-induced adaptive immune suppression and thereby enable pancreatic ductal adenocarcinoma progression PMID: 27049944
    46. High CXCL1 expression is a poor prognostic biomarker in metastatic colorectal cancer. PMID: 26104296
    47. urinary CXCL1 as a new non-invasive predictor of IgAN progression PMID: 25816025
    48. CXCL1 expression was a negative prognostic factor. PMID: 25175281
    49. There was a significant positive correlation between CXCL-1 levels in the vitreous and the extent of the retinal detachment. PMID: 25766782
    50. CXCL1 expression was highly upregulated in patients with alcoholic hepatitis. PMID: 25930080

    顯示更多

    收起更多

  • 亞細(xì)胞定位:
    Secreted.
  • 蛋白家族:
    Intercrine alpha (chemokine CxC) family
  • 數(shù)據(jù)庫鏈接:

    HGNC: 4602

    OMIM: 155730

    KEGG: hsa:2919

    STRING: 9606.ENSP00000379110

    UniGene: Hs.708652